Free Trial

Bruker (BRKR) Stock Price, News & Analysis

Bruker logo
$41.80 -0.38 (-0.90%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$41.72 -0.08 (-0.20%)
As of 06/27/2025 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bruker Stock (NASDAQ:BRKR)

Key Stats

Today's Range
$41.11
$42.38
50-Day Range
$35.50
$42.18
52-Week Range
$34.10
$72.94
Volume
5.25 million shs
Average Volume
1.70 million shs
Market Capitalization
$6.33 billion
P/E Ratio
80.38
Dividend Yield
0.48%
Price Target
$52.89
Consensus Rating
Hold

Company Overview

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Bruker Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
98th Percentile Overall Score

BRKR MarketRank™: 

Bruker scored higher than 98% of companies evaluated by MarketBeat, and ranked 13th out of 670 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bruker has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 4 buy ratings, 6 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Bruker has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Bruker's stock forecast and price target.
  • Earnings Growth

    Earnings for Bruker are expected to grow by 17.10% in the coming year, from $2.69 to $3.15 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bruker is 80.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.02.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bruker is 80.38, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 35.66.

  • Price to Earnings Growth Ratio

    Bruker has a PEG Ratio of 2.81. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Bruker has a P/B Ratio of 3.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Bruker's valuation and earnings.
  • Percentage of Shares Shorted

    9.59% of the float of Bruker has been sold short.
  • Short Interest Ratio / Days to Cover

    Bruker has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Bruker has recently increased by 6.24%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Bruker has a dividend yield of 0.48%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Bruker does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Bruker is 38.46%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Bruker will have a dividend payout ratio of 6.35% next year. This indicates that Bruker will be able to sustain or increase its dividend.

  • Read more about Bruker's dividend.
  • Percentage of Shares Shorted

    9.59% of the float of Bruker has been sold short.
  • Short Interest Ratio / Days to Cover

    Bruker has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Bruker has recently increased by 6.24%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Bruker has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.81 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Bruker this week, compared to 10 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added Bruker to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bruker insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,043.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    27.30% of the stock of Bruker is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    79.52% of the stock of Bruker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Bruker's insider trading history.
Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

BRKR Stock News Headlines

Deploy the Income Machine for yourself this summer
Wall Street seems to be losing faith in stocks we thought were their favorites. Take Apple for example. Normally, new updates tend to rally their stock price. But here's what happened last week. The way I see it, Apple’s downtrend may continue as we inch closer to the thick of summer. And if I made a list of stocks to trade this summer, Apple most likely won't make that list. But rather than gamble on Apple stock... Buy shares outrightly... Or even keep an eye out for their next tech revolution before we act… A better idea might be to just zone in on the tickers and setups worth trading in the summer months.
See More Headlines

BRKR Stock Analysis - Frequently Asked Questions

Bruker's stock was trading at $58.62 on January 1st, 2025. Since then, BRKR shares have decreased by 28.7% and is now trading at $41.80.
View the best growth stocks for 2025 here
.

Bruker Corporation (NASDAQ:BRKR) announced its quarterly earnings results on Wednesday, May, 7th. The medical research company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.01. The company's revenue for the quarter was up 11.0% compared to the same quarter last year.
Read the conference call transcript
.

Bruker subsidiaries include PMOD Technologies, Arxspan, Alicona Imaging, JPK In­stru­ments, Luxendo, Hysitron, InVivo Biotech Services GmbH, and more.

Bruker's top institutional investors include T. Rowe Price Investment Management Inc. (8.17%), Vanguard Group Inc. (6.96%), Pallas Capital Advisors LLC (6.26%) and Sculptor Capital LP (1.71%). Insiders that own company stock include Frank H Laukien, Richard A Packer, Gerald N Herman, Hermann Fritz Requardt, Cynthia M Friend and Thomas Bures.
View institutional ownership trends
.

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bruker investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
5/07/2025
Record date for 6/27 Dividend
6/16/2025
Ex-Dividend for 6/27 Dividend
6/16/2025
Dividend Payable
6/27/2025
Today
6/29/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
INSTRU - SCIENTFC
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:BRKR
Employees
11,396
Year Founded
1960

Price Target and Rating

Average Stock Price Target
$52.89
High Stock Price Target
$72.00
Low Stock Price Target
$40.00
Potential Upside/Downside
+26.5%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
10 Analysts

Profitability

Trailing P/E Ratio
80.38
Forward P/E Ratio
15.54
P/E Growth
2.81
Net Income
$113.10 million
Pretax Margin
4.65%

Debt

Sales & Book Value

Annual Sales
$3.37 billion
Cash Flow
$3.59 per share
Price / Cash Flow
11.64
Book Value
$11.85 per share
Price / Book
3.53

Miscellaneous

Free Float
110,164,000
Market Cap
$6.33 billion
Optionable
Optionable
Beta
1.16

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:BRKR) was last updated on 6/29/2025 by MarketBeat.com Staff
From Our Partners